Rakuten Securities, Inc. Roivant Sciences Ltd. Transaction History
Rakuten Securities, Inc.
- $230 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
314Shares Held
495MCall Options Held
1.29MPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$838 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$813 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$784 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$416 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$345 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.28B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...